CoAxia
Medical device company engaged in the R&D of therapy and treatment solutions for cerebral ischemia.
Launch date
Employees
Market cap
-
Enterprise valuation
€18—27m (Dealroom.co estimates Mar 2011.)
Maple Grove Minnesota (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$11.0m | Series C | ||
| N/A | $11.5m | Series C | |
$21.5m | Series D | ||
| N/A | $5.0m | Early VC | |
N/A | Acquisition | ||
| Total Funding | €60.5m | ||
Related Content
Recent News about CoAxia
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.